| | | | | |
AMPH Amphastar Pharmaceuticals, Inc. | $19.6600 | +0.10 % | $960.34M | $135.59K | |
REPL Replimune Group, Inc. | $11.5800 | +0.00 % | $960.31M | $1.29M | |
| $57.2400 | +0.00 % | $957.77M | $140.54K | |
AIO Virtus Artificial Intelligence & Technology Opportunities Fund | $27.0400 | +0.00 % | $957.06M | $63.99K | |
AVTX Avalo Therapeutics, Inc. Common Stock | $18.5300 | -1.65 % | $956.69M | $1.63M | |
HSLV Highlander Silver Corp. | $5.0000 | +0.00 % | $956.09M | $418.43K | |
| $54.5650 | +0.05 % | $955.17M | $38.51K | |
SANA Sana Biotechnology, Inc. Common Stock | $4.0100 | +0.00 % | $951.75M | $2.51M | |
ABX Abacus Global Management, Inc. | $11.8600 | +0.00 % | $950.59M | $507.49K | |
ANRO Alto Neuroscience Inc. | $24.7800 | +0.00 % | $948.94M | $381.06K | |
GDRX GoodRx Holdings, Inc. Class A Common Stock | $3.0600 | +0.33 % | $948.29M | $1.26M | |
RHLD Resolute Holdings Management, Inc. | $148.34 | +0.00 % | $948.28M | $46.75K | |
BTZ BlackRock Credit Allocation Income Trust | $10.2600 | +0.00 % | $948.17M | $64.94K | |
DBVT DBV Technologies S.A. | $15.8100 | -0.06 % | $947.57M | $189.78K | |
PHAR Pharming Group N.V. ADS, each representing 10 ordinary shares | $13.6250 | -1.05 % | $947.08M | $4.32K | |
